Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Icecure Medical Ltd ICCM

Technology Medical Care Scientific & Technical Instruments
Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ICCM)

Breast Cancer Patients who Underwent IceCure's ProSense® Cryoablation in Japan Reported Significantly Higher Satisfaction than Patients who Underwent Standard of Care Surgery

PR Newswire 5 days ago

IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense(TM) Cryoablation System in Israel

PR Newswire February 24, 2025

IceCure's ProSense® in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical Community Anticipates FDA's Market Authorization Decision

PR Newswire February 4, 2025

IceCure Files for Regulatory Approval of ProSense® Cryoablation System in China

PR Newswire January 27, 2025

IceCure Medical CEO Issues Letter to Shareholders & Reports Increase of 42% in ProSense® Sales for 2024 in North America

PR Newswire January 13, 2025

IceCure Medical Regains Full Nasdaq Compliance with Nasdaq Minimum Closing Bid Price Rule

PR Newswire January 6, 2025

European Patent Office Issues Intention to Grant Notice to IceCure for its Next-Generation Cryoablation Technology

PR Newswire January 3, 2025

Data on IceCure's ProSense® Cryoablation for Low-Risk Breast Cancer Presented at Radiological Society of North America's 2024 Annual Meeting

PR Newswire December 16, 2024

IceCure's ProSense® Cryoablation Safe and Effective in Destruction of Kidney Tumors with 88.7% Recurrence-Free Rate Based on Interim ICESECRET Study Results

PR Newswire December 5, 2024
View More News ››

Opinion & Analysis (NDAQ:ICCM)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ICCM)

IceCure Medical to Report Third Quarter 2024 Financial & Ope

BREAKING NEWS: $ICCM IceCure Medical to Report Third Quarter 2024 Financial & Operational Results on November 26, 2024IceCure...
whytestocks - November 20, 2024

IceCure Receives Notice of Allowance from U.S. Patent and Tr

JUST IN: $ICCM IceCure Receives Notice of Allowance from U.S. Patent and Trademark Office for its Next-Generation Cryoablation...
whytestocks - October 21, 2024

IceCure Medical Requests Marketing Authorization to Treat Ea

News; $ICCM IceCure Medical Requests Marketing Authorization to Treat Early-Stage Breast Cancer from FDA2024-04-15 10:06:29 ET DENVER...
whytestocks - April 15, 2024

ICCM.....1st scalp of the a.m ; )

Call it "Lunch Money" 
Iseneschal - April 15, 2024

Fourth BRIIT Conference in India Features IceCure's ProSense

Breaking News: $ICCM Fourth BRIIT Conference in India Features IceCure's ProSense&#xAE; in Breast Cancer Imaging &...
whytestocks - February 27, 2024

An unbelievable N.R. and nothing.

Study Using IceCure's ProSense® Treatment Results in 100% Tumor Reduction in Early-Stage Breast Cancer
billybob22 - February 27, 2024
View more Bullboard ››

Coniagas Battery Metals Inc.

Coniagas Battery Metals Inc.

Coniagas Battery Metals Inc. is a Canada-based exploration and mining company. The Company is focused on nickel, copper, and ...
View More »